Technology | June 29, 2006

Ablation Catheter Provides Latest Cure for Atrial Flutter


A new way to block the abnormal electrical pathways that cause atrial flutter, the IBI Therapy Dual 8 Ablation Catheter and IBI 1500T6 Generator by Irvine Biomedical, Inc. obtained FDA clearance in December.
The catheter is placed into a vein near the groin and threaded through the vein into the chambers of the heart. The catheter end outside the body is connected to the electrical system that allows the physician to view the beating heart on a screen. By watching the screen, the doctor can place the catheter in exactly the correct spot to treat the abnormal heartbeats. Once the catheter is in place, the doctor turns on the energy from the generator to heat the tip of the catheter, ablating a small part of the heart that causes atrial flutter. The procedure has been shown to cure atrial flutter in approximately 93 percent of patients, but should not be used in patients who have an infection in the blood or a tumor or blood clot inside the heart.


Related Content

News

Oct. 10, 2025 — Johnson & Johnson MedTech, in collaboration with the Heart Rhythm Clinical and Research Solutions, LLC ...

Home October 13, 2025
Home
News

Sept. 2, 2025 — Johnson & Johnson MedTech has announced acute safety and effectiveness results from the Varipure ...

Home September 05, 2025
Home
News

Sept. 3, 2025 — Kardium Inc. recently announced it has received pre-market approval (PMA) for the Globe Pulsed Field ...

Home September 03, 2025
Home
News

July 14, 2025  –  Johnson & Johnson MedTech has announced U.S. Food and Drug Administration (FDA) approval of an update ...

Home July 14, 2025
Home
News

July 7, 2025 — Catheter ablation is a minimally invasive treatment for abnormal heart rhythms. It is often successful in ...

Home July 09, 2025
Home
News

June 4, 2025 — A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons ...

Home June 04, 2025
Home
News

April 24, 2025 – The Heart Rhythm Society (HRS) and the American College of Cardiology (ACC) have released a scientific ...

Home April 24, 2025
Home
News

April 9, 2025 — Merit Medical Systems has announced the U.S. commercial release of its Ventrax Delivery System. Ventrax ...

Home April 16, 2025
Home
News

March 27, 2025 — Abbott recently announced it has received CE Mark in Europe for the Volt PFA System to treat patients ...

Home March 27, 2025
Home
News

Oct. 24, 2024 — Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera ...

Home October 30, 2024
Home
Subscribe Now